ISPC Stock: iSpecimen Inc. Stock Price, Analysis & Insights
Get live ispc stock price $1.95, comprehensive iSpecimen Inc. stock analysis, charts, news, and expert forecast. Real-time ispc stock data and investment insights.
Company Overview
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Company Information
- CEO
- Robert Bradley Lim
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 24
Contact Information
- Website
- https://ispecimen.com
- Address
- 450 Bedford Street
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 7.76M market capitalization
- Trading Volume: 68.75M shares traded today
- Price Range: 52-week range of $0.64 - $8.30
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for iSpecimen Inc.
iSpecimen Inc. (ISPC) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. With a current market capitalization of 7.76M, the company represents a significant player in its market. The stock is currently trading at $1.95 with a positivedaily change of 47.73%.
The company's 24 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.22, beta of 1.61, and 52-week price range from $0.64 to $8.30when evaluating investment opportunities.
Why Invest in iSpecimen Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Robert Bradley Lim
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.